Rosenblum Mark J 4
4 · Salarius Pharmaceuticals, Inc. · Filed Nov 5, 2021
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Common Stock
2021-11-03$0.72/sh+7,787$5,591→ 34,073 total
Footnotes (1)
- [F1]The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan.